期刊文献+

乙型肝炎病毒表面抗原定量检测和临床应用研究进展 被引量:4

原文传递
导出
摘要 乙型肝炎病毒表面抗原(hepatitisBsurfaceantigen,HBsAg)是病毒的外膜结构蛋白多肽,人体感染乙型肝炎病毒(hepatitisBvirus,HBV)后4~7周就能从血清内检测到HBsAg,但HBsAg本身不具有传染性,以往临床一直将HBsAg作为HBV感染的一个指标;近年来,随着HBsAg定量检测技术的进步和不断开展相关的研究,人们对HBsAg定量与慢性乙型肝炎自然史、疾病转归以及疗效预测的关系逐渐变得乙型肝炎病毒清晰起来,HBsAg这个“古老”的指标再次焕发出新的生命。
作者 梁柱石
出处 《中华实验和临床感染病杂志(电子版)》 CAS 2013年第4期123-125,共3页 Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition)
  • 相关文献

参考文献31

  • 1吴昊,罗进,郭晏海,王小明,闫小君,李丁.蛋白质芯片定量检测乙肝表面抗原系统的建立[J].中国卫生检验杂志,2008,18(5):857-859. 被引量:1
  • 2陈玮,李明,吴英松,李妙艳,何蕴韶.用液相芯片技术定量测定人血清CEA、AFP和HBsAg[J].中山大学学报(医学科学版),2007,28(1):105-109. 被引量:10
  • 3骆抗先.乙型肝炎基础和临床.2版.北京:人民卫生出版社,2001.
  • 4Chen CH, Lee CM, Wang JH, et al. Correlation of quantitative assay of hepatitis B surface antigen and HBVDNA levels in asymptomatic hepatitis B virus carriers. Eur J Gastroenterol Hepatol.2004,16(11): 1213-1218.
  • 5Su TH, Hsu, CS, Chen CL, et al. Serum hepatitis B surface antigen concentration conelates with HBVDNA level in patients with chronic hepatitis B. Antivir ther,2010,15(8): 1133-1139.
  • 6Deguchi M, Yamashita N, Kagita M, et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay. J Virol Methods,2004,115(2):217-222.
  • 7Jaroszewicz J, Calle SB, Warsthorm K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol,2010,52(4): 514-522.
  • 8Nguyen T, Thompson A J, Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol,2010,52(4):508-513.
  • 9Kuhns MC, Kleinman SH, McNamara AL, et al. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion,2004,44(9):1332-1339.
  • 10王临旭,黄长形,李新红,王毕娟,尹晨.慢性乙型肝炎病毒感染自然史中表面抗原水平的研究[J].中华临床医师杂志(电子版),2011,5(17):5122-5124. 被引量:7

二级参考文献48

  • 1慢性乙型肝炎防治指南[J].中华传染病杂志,2005,23(6):421-431. 被引量:824
  • 2Gerald C Kimbi,Anna Kramvis,Michael C Kew.Integration of hepatitis B virus DNA into chromosomal DNA during acute hepatitis B[J].World Journal of Gastroenterology,2005,11(41):6416-6421. 被引量:12
  • 3European Association for the Study of the Liver.EASL clinical practice guidelines; management of chronic hepatitis B.J Hepatol,2009,50:227-242.
  • 4Lok AS,McMahon BJ.Chronic hepatitis B:update 2009.Hepatology,2009,50:661-662.
  • 5Cooksley WG,Piratvisuth T,Lee SD,et al.Peginterferon alpha-2a (40 kDa):an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.J Viral Hepat,2003,10:298-305.
  • 6Lau GK,Piratvisuth T,Luo KX,et al.Peginterferon Alfa-2a,lamivudine,and the combination for HBeAg-positive chronic hepatitis B.N Engl J Med,2005,352:2682-2695.
  • 7Marcellin P,Lau GK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B.N Engl J Med,2004,351:1206-1217.
  • 8Janssen HL,van Zonneveld M,Senturk H,et al.Pegylated interferon alfa-2b alone or in combination with lamivudinefor HBeAg-positive chronic hepatitis B:a randomised trial.Lancet,2005,365:123-129.
  • 9Lau GKK,Piratvisuth T,Luo KX,et al.Durability of response and occurrence of late response to peginterferon alpha-2a (40KD)[PEGASYS] one year post-treatment in patients with HBeAg-positive chronic hepatitis B.J Hepatology,2006,44(Suppl 2),S23-24.
  • 10Marcellin P,Bonino F,Lau GK,et al.Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.Gastroenterology,2009,136:2169-2179.el-e4.

共引文献164

同被引文献25

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部